MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 69 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,310,335 | +1168012.5% | 136,403 | +787.9% | 0.00% | – |
| Q1 2023 | $369 | -99.9% | 15,363 | -33.5% | 0.00% | – |
| Q1 2022 | $509,000 | -33.3% | 23,115 | -51.7% | 0.00% | – |
| Q4 2021 | $763,000 | -71.1% | 47,861 | -63.9% | 0.00% | -100.0% |
| Q3 2021 | $2,641,000 | +239.5% | 132,586 | +194.8% | 0.00% | – |
| Q2 2021 | $778,000 | -52.6% | 44,971 | -45.7% | 0.00% | -100.0% |
| Q1 2021 | $1,642,000 | -66.0% | 82,842 | -70.1% | 0.00% | -66.7% |
| Q4 2020 | $4,834,000 | +18.9% | 276,875 | +31.2% | 0.00% | -40.0% |
| Q3 2020 | $4,067,000 | +1827.5% | 211,079 | +1847.6% | 0.01% | – |
| Q2 2020 | $211,000 | -84.2% | 10,838 | -88.6% | 0.00% | -100.0% |
| Q1 2020 | $1,334,000 | +144.3% | 95,297 | +327.9% | 0.00% | +200.0% |
| Q4 2019 | $546,000 | -56.7% | 22,271 | -82.2% | 0.00% | -50.0% |
| Q3 2019 | $1,261,000 | – | 125,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |